DONG-A ST CO., LTD.

Other languages Dong-A ST Co., Ltd.

Equities

A170900

KR7170900005

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
67,600 ^KRW	+0.45%		-2.31%	-2.17%

03-18	Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-24	GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-18
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara	01-05
Dong-A ST Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion	23-08-31
Dong-A ST Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Dong-A ST Co., Ltd. announces an Equity Buyback for 38,373 shares.	23-07-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-07-25
EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar	23-07-17
Dong-A ST Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Dong-A ST Co., Ltd. announces an Equity Buyback for 45,872 shares.	23-04-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-04-25
Dong-A ST Co., Ltd. announces an Equity Buyback for 40,519 shares.	23-01-25
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-01-25
Dong-A ST Co., Ltd. Demonstrates Therapeutic Equivalence Between DMB-3115 and Stelara in Global Phase III	23-01-17
Dong-A ST Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Dong-A ST Co., Ltd. announces an Equity Buyback for 50,301 shares.	22-10-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	22-10-25
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies	22-09-15
Dong-A ST Co., Ltd. and Beactica Therapeutics AB Mutually Agree to Conclude Oncology Collaboration	22-09-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer